Peptide therapy postpartum: what the science says vs. TikTok

What's this video probably claiming?

Based on the hashtags and caption framing, @thewellnessmomera is almost certainly pitching a peptide stack, possibly including GLP-1 adjacent compounds like ipamorelin or CJC-1295, as a postpartum body composition tool. The #peppercommunity hashtag places her squarely in the Pepper app telehealth ecosystem, which markets peptide therapy to women. The #biohack framing and "changed my life" language pattern strongly suggest she's describing accelerated fat loss, improved energy, or recovery benefits attributed to one or more injectable peptides. The disclaimer about not promoting disordered behaviors is a standard legal buffer used by creators in this space, and its presence tells you the content probably walks right up to body image territory without technically crossing it.

The postpartum angle is worth flagging immediately. Peptide therapy in postpartum women is an essentially unstudied population in formal clinical trials. Whatever she's experienced, it cannot be attributed to peptides with scientific confidence.

What does the science actually show?

The peptides most likely being discussed, CJC-1295 and ipamorelin, are growth hormone secretagogues. CJC-1295 with DAC has been studied in healthy adults at doses producing sustained GH elevation, with Teichman et al. (2006, Journal of Clinical Endocrinology and Metabolism) showing meaningful GH pulse amplification. Ipamorelin showed cleaner GH release with fewer cortisol and prolactin side effects than GHRP-6 in Raun et al. (1998, European Journal of Endocrinology). That's where the legitimate science mostly stops for these compounds in wellness contexts.

GHK-Cu has some wound healing and collagen synthesis data, primarily in vitro or animal models. MK-677 increases IGF-1 but also increases fasting glucose and causes water retention in a meaningful percentage of users. Sigalos and Pastuszak (2018, Sexual Medicine Reviews) noted the evidence base for most peptides in clinical use is thin and largely extrapolated from pharmacological studies, not randomized controlled trials in healthy populations seeking body recomposition.

Where does the social media noise diverge from clinical reality?

The gap here is substantial. TikTok peptide content routinely conflates early-phase pharmacology research with clinical efficacy. A compound showing GH elevation in a controlled study becomes "burns fat and builds muscle" in a 60-second video. The #glp1 hashtag on this post is particularly misleading because true GLP-1 receptor agonists like semaglutide and tirzepatide have strong phase 3 trial data behind them. Ipamorelin does not. Lumping them together via hashtag is a rhetorical move, not a clinical equivalency.

Postpartum physiology adds another layer of complexity that creators never address. Prolactin levels, insulin sensitivity shifts, thyroid changes, and sleep deprivation all interact with hormone axes in ways that make peptide effects genuinely unpredictable. No published study has examined GH secretagogue use in recently postpartum women, breastfeeding or otherwise. Recommending these compounds in this population based on personal experience is not biohacking. It's an uncontrolled n=1 experiment being broadcast to 10,600 people.

What should you actually know?

Peptide therapy through regulated telehealth platforms involves compounds that are largely compounded by 503A or 503B pharmacies. Compounded peptides are not FDA-approved drugs, and their purity, sterility, and dosing accuracy vary by pharmacy. This is not a technicality. A 2022 analysis of compounded semaglutide products found significant concentration variability across samples. The same risk applies to injectable peptides.

If you're postpartum and curious about body composition support, there are interventions with actual evidence: resistance training, adequate protein intake (1.6-2.2g/kg/day per Morton et al., 2018, British Journal of Sports Medicine), and addressing sleep where possible. These aren't exciting content. They don't generate affiliate revenue. But they have randomized trial data behind them, which injectable peptides marketed through TikTok simply do not.

• Any peptide therapy postpartum should involve a physician who knows your full hormonal and obstetric history, not a telehealth form and a wellness creator's referral link.
• The burden of proof is on the therapy to show safety in this population. That proof does not currently exist.